Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from telehealth

8 Health-Care Policy Changes That Will Hit Your Wallet After 50

Turning 50 is a milestone, but it also marks a turning point in how health-care policy changes can affect your wallet. As you get older, your health needs may increase, and so does your exposure to shifting rules and costs. The landscape of health insurance, Medicare, prescription drug pricing, and…

The Free Financial Advisor

MD Integrations: The Platform Making Virtual Care Feel Seamless

MD Integrations (MDI) was founded in 2020 by Dr. Marc Serota, a triple board-certified physician.

International Business Times

How Advances in Telemedicine Are Changing Senior Health Care Access

Telemedicine has moved from a pandemic necessity to a permanent part of senior care. For older adults who face mobility issues, long waits, or transportation...

Saving Advice

From analysis to the latest developments in health,
read the most diverse news in one place.

Amazon Stock Is Trending Thursday: What's Going On?

Amazon.com Inc (NASDAQ:AMZN) shares are trading slightly lower on Thursday. The company announced an expansion of its telehealth service ahead of earnings later this month.

Benzinga

Why Medicare Fraud Is Surging—and How to Protect Yourself

Medicare fraud isn’t new, but it’s becoming more sophisticated—and more costly. Criminals are now using advanced technology, identity theft, and even fake healthcare providers to...

Saving Advice

Telehealth Is the Lifeline Our Broken System Needs

Telehealth reduces missed appointments, improves chronic disease management, and expands access in rural areas, which are all key to prevention and recovery.

International Business Times

Teladoc (TDOC) Shares Climb On Bullish Commentary From Citron Research

Shares of Teladoc Health Inc (NYSE:TDOC) are surging Friday morning after Citron Research posted bullish comments on the telehealth provider, asserting they were “not wrong, just early” on the stock’s potential. The commentary sparked renewed investor interest, pushing the stock higher in early trading.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Doctors cancel telehealth appointments as Medicare coverage lapses - Roll Call

When government funding expired this week, so did a health care policy that allowed Medicare to cover telehealth services.

Roll Call

Government Shutdown and Seniors: What You Need to Know About Social Security and Healthcare

Congress has hit another deadlock. Democrats and Republicans failed to pass a stopgap funding bill, resulting in a government shutdown as the new fiscal year...

Saving Advice

Louisiana issues a warrant to arrest California doctor accused of mailing abortion pills

Louisiana has issued a warrant to arrest a California doctor accused of mailing abortion pills

The Independent UK

Medicare’s Mental Health Expansion Sounds Great—Until You See Who’s Still Left Out

In recent years, Medicare has expanded mental health benefits, promising seniors better access to care. The updates include coverage for telehealth therapy, a broader range...

Saving Advice

FDA takes aim at Hims and other telehealth services in drug advertising blitz

The Trump administration has issued its first warnings to online services that offer unofficial versions of popular drugs like the blockbuster obesity treatment Wegovy

The Independent UK

Friday Plans Reviews (2025): Should You Get Friday Plans? An Honest Look at Friday Plans Pills

To satisfy a growing number of reader questions about the service, this article delves into Friday Plans reviews, the ordering process, and the safety standards behind Friday Plans pills.

Medical Daily

Discounted Ozempic Could Deflate ETF Optimism Around Hims & Hers

Hims Hers Health Inc (NYSE:HIMS) investors can’t catch a break. Less than two months since Novo Nordisk AS (NYSE:NVO) terminated its Wegovy partnership with the telehealth company abruptly, the pharma giant is again in the news, this time partnering with GoodRx Holdings Inc (NASDAQ:GDRX) to provide discounted access to Ozempic…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Clever Dude

5 Ways ‘Hims’ Searches Are Shaping Men’s Health Conversations

In recent years, men’s health has shifted from being a quiet, private matter to an open conversation fueled by technology and data. One of the biggest players in that transformation is Hims, the telehealth platform known for discreetly delivering prescription and wellness products straight to consumers. Search data from Hims…

Benzinga

Hims & Hers Remains Outside Novo Nordisk's Growing Legal Storm For Now

Hims Hers Health Inc. (NYSE:HIMS) has been one of 2025’s hottest telehealth stocks, nearly doubling in value year to date, but a deepening clash with Novo Nordisk A/S (NYSE:NVO) over compounded weight-loss drugs, and shifting FDA rules, has turned momentum into headwinds, sending shares sliding 10% in the past three…

Benzinga

Hims & Hers Stock Up, Nearing All-Time High As Weight-Loss Giants Stumble

Shares of telehealth company Hims Hers Health Inc (NYSE:HIMS) are up Thursday afternoon, and at one point, approached a new all-time high. The rally comes amid significant headwinds for major pharmaceutical companies in the lucrative weight-loss drug market.

Benzinga

HIMS Crashes On Novo GLP-1 Fallout: Buy The Dip Or Bail?

Telehealth darling Hims Hers Health Inc (NYSE:HIMS) got slapped with a 34% stock crash on Monday. Novo Nordisk A/S (NYSE:NVO) ended their relationship – and it wasn't amicable.

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times UK

Why Did Novo Nordisk Pull the Plug on Hims Collaboration?

Novo Nordisk ended its partnership with Hims & Hers on 23 June 2025, accusing the telehealth firm of selling unsafe, unapproved Wegovy knock-offs. Hims' stock tanked, and legal risks loom.

International Business Times UK

Hims Stock Tumbles Down After Abrupt Exit of Novo Nordisk: Here's Everything That Went Wrong

Novo Nordisk alleged that some telehealth entities, including Hims & Hers, used illicit semaglutide sourced from unregulated Chinese manufacturers not approved or inspected by the FDA.

Reason

Abortion Rates Keep Rising After Dobbs

Strict abortion bans do not seem to be seriously stopping abortions.

The Guardian - US

Abortions in the US are on the rise three years after Roe v Wade was overturned

A growing number of abortions happen through telehealth – including for women in states with strict bans

The Independent UK

The number of abortions kept rising in 2024 because of telehealth prescriptions, report finds

A new report finds that the number of abortions in the U.S. grew in 2024 as more women obtained pills through telehealth

Euronews

US women are defying abortion bans by getting pregnancy-ending drugs online. That could change

After some US states tightened their abortion laws, women turned to telehealth clinics in more liberal states to access abortion medications.

The Independent UK

Inside the legal fight over the telehealth clinics that help women defy abortion bans

Every month, thousands of women evade abortion bans in their home states by turning to telehealth clinics willing to send them pregnancy-ending drugs through the mail

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.